• Sodium Voltage-gated Channel Alpha Subunit 1 (SCN1A) Gene Mutation Analysis
  • Duodenal Mucosal Biopsy, Endoscopic
  • Lysosomal Acid Lipase, Enzyme Activity
  • Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • Dopamine D2L receptor (DRD2L) Antibody, IgG
  • Osteogenesis Imperfecta and Low Bone Density Gene Mutation Panel, NGS
  • Thyroxine (T4), Total
  • Norfentanyl, Urine
  • Peripheral Myelin Protein 22 (PMP22) Gene Mutation Analysis
  • Dermatophytosis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Inhibin A and B, Tumor Marker
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Inhibin A and B, Tumor Marker
Medical Test

Turnaround Time
Access to Inhibin A and B, Tumor Marker is restricted.